Table of Contents China Candidiasis Therapeutics Market Research Report 2018 1 Candidiasis Therapeutics Overview 1.1 Product Overview and Scope of Candidiasis Therapeutics 1.2 Classification of Candidiasis Therapeutics by Product Category 1.2.1 China Candidiasis Therapeutics Sales (K Pcs) Comparison by Type (2013-2025) 1.2.2 China Candidiasis Therapeutics Sales (K Pcs) Market Share by Type in 2017 1.2.3 Doxorubicin 1.2.4 Cisplatin 1.2.5 7Carboplatin 1.2.6 Etoposide 1.2.7 Ifosfamide 1.2.8 Cyclophosphamide 1.2.9 Methotrexate 1.2.10 Vincristine 1.3 China Candidiasis Therapeutics Market by Application/End Users 1.3.1 China Candidiasis Therapeutics Sales (K Pcs) and Market Share Comparison by Applications (2013-2025) 1.3.2 Multispecialty Hospitals 1.3.3 Cancer Research Institutes 1.3.4 Others 1.4 China Candidiasis Therapeutics Market by Region 1.4.1 China Candidiasis Therapeutics Market Size (Million USD) Comparison by Region (2013-2025) 1.4.2 South China Candidiasis Therapeutics Status and Prospect (2013-2025) 1.4.3 East China Candidiasis Therapeutics Status and Prospect (2013-2025) 1.4.4 Southwest China Candidiasis Therapeutics Status and Prospect (2013-2025) 1.4.5 Northeast China Candidiasis Therapeutics Status and Prospect (2013-2025) 1.4.6 North China Candidiasis Therapeutics Status and Prospect (2013-2025) 1.4.7 Central China Candidiasis Therapeutics Status and Prospect (2013-2025) 1.5 China Market Size (Sales and Revenue) of Candidiasis Therapeutics (2013-2025) 1.5.1 China Candidiasis Therapeutics Sales (K Pcs) and Growth Rate (%)(2013-2025) 1.5.2 China Candidiasis Therapeutics Revenue (Million USD) and Growth Rate (%)(2013-2025) 2 China Candidiasis Therapeutics Market Competition by Players/Manufacturers 2.1 China Candidiasis Therapeutics Sales and Market Share of Key Players/Manufacturers (2013-2018) 2.2 China Candidiasis Therapeutics Revenue and Share by Players/Manufacturers (2013-2018) 2.3 China Candidiasis Therapeutics Average Price (USD/Pcs) by Players/Manufacturers (2013-2018) 2.4 China Candidiasis Therapeutics Market Competitive Situation and Trends 2.4.1 China Candidiasis Therapeutics Market Concentration Rate 2.4.2 China Candidiasis Therapeutics Market Share of Top 3 and Top 5 Players/Manufacturers 2.4.3 Mergers & Acquisitions, Expansion in China Market 2.5 China Players/Manufacturers Candidiasis Therapeutics Manufacturing Base Distribution, Sales Area, Product Types 3 China Candidiasis Therapeutics Sales and Revenue by Region (2013-2018) 3.1 China Candidiasis Therapeutics Sales (K Pcs) and Market Share by Region (2013-2018) 3.2 China Candidiasis Therapeutics Revenue (Million USD) and Market Share by Region (2013-2018) 3.3 China Candidiasis Therapeutics Price (USD/Pcs) by Regions (2013-2018) 4 China Candidiasis Therapeutics Sales and Revenue by Type/ Product Category (2013-2018) 4.1 China Candidiasis Therapeutics Sales (K Pcs) and Market Share by Type/ Product Category (2013-2018) 4.2 China Candidiasis Therapeutics Revenue (Million USD) and Market Share by Type (2013-2018) 4.3 China Candidiasis Therapeutics Price (USD/Pcs) by Type (2013-2018) 4.4 China Candidiasis Therapeutics Sales Growth Rate (%) by Type (2013-2018) 5 China Candidiasis Therapeutics Sales by Application (2013-2018) 5.1 China Candidiasis Therapeutics Sales (K Pcs) and Market Share by Application (2013-2018) 5.2 China Candidiasis Therapeutics Sales Growth Rate (%) by Application (2013-2018) 5.3 Market Drivers and Opportunities 6 China Candidiasis Therapeutics Players/Suppliers Profiles and Sales Data 6.1 Novartis AG 6.1.1 Company Basic Information, Manufacturing Base and Competitors 6.1.2 Candidiasis Therapeutics Product Category, Application and Specification 6.1.2.1 Product A 6.1.2.2 Product B 6.1.3 Novartis AG Candidiasis Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018) 6.1.4 Main Business/Business Overview 6.2 Amgen 6.2.1 Company Basic Information, Manufacturing Base and Competitors 6.2.2 Candidiasis Therapeutics Product Category, Application and Specification 6.2.2.1 Product A 6.2.2.2 Product B 6.2.3 Amgen Candidiasis Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018) 6.2.4 Main Business/Business Overview 6.3 F. Hoffmann-La Roche Ltd. 6.3.1 Company Basic Information, Manufacturing Base and Competitors 6.3.2 Candidiasis Therapeutics Product Category, Application and Specification 6.3.2.1 Product A 6.3.2.2 Product B 6.3.3 F. Hoffmann-La Roche Ltd. Candidiasis Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018) 6.3.4 Main Business/Business Overview 6.4 Bayer-Algeta 6.4.1 Company Basic Information, Manufacturing Base and Competitors 6.4.2 Candidiasis Therapeutics Product Category, Application and Specification 6.4.2.1 Product A 6.4.2.2 Product B 6.4.3 Bayer-Algeta Candidiasis Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018) 6.4.4 Main Business/Business Overview 6.5 Merrion Pharmaceuticals Plc. 6.5.1 Company Basic Information, Manufacturing Base and Competitors 6.5.2 Candidiasis Therapeutics Product Category, Application and Specification 6.5.2.1 Product A 6.5.2.2 Product B 6.5.3 Merrion Pharmaceuticals Plc. Candidiasis Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018) 6.5.4 Main Business/Business Overview 6.6 Ablynx 6.6.1 Company Basic Information, Manufacturing Base and Competitors 6.6.2 Candidiasis Therapeutics Product Category, Application and Specification 6.6.2.1 Product A 6.6.2.2 Product B 6.6.3 Ablynx Candidiasis Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018) 6.6.4 Main Business/Business Overview 6.7 Genta Incorporated 6.7.1 Company Basic Information, Manufacturing Base and Competitors 6.7.2 Candidiasis Therapeutics Product Category, Application and Specification 6.7.2.1 Product A 6.7.2.2 Product B 6.7.3 Genta Incorporated Candidiasis Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018) 6.7.4 Main Business/Business Overview 6.8 Galapagos NV 6.8.1 Company Basic Information, Manufacturing Base and Competitors 6.8.2 Candidiasis Therapeutics Product Category, Application and Specification 6.8.2.1 Product A 6.8.2.2 Product B 6.8.3 Galapagos NV Candidiasis Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018) 6.8.4 Main Business/Business Overview 6.9 Catena Pharmaceuticals Inc. 6.9.1 Company Basic Information, Manufacturing Base and Competitors 6.9.2 Candidiasis Therapeutics Product Category, Application and Specification 6.9.2.1 Product A 6.9.2.2 Product B 6.9.3 Catena Pharmaceuticals Inc. Candidiasis Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018) 6.9.4 Main Business/Business Overview 6.10 Digna Biotech S.L. 6.10.1 Company Basic Information, Manufacturing Base and Competitors 6.10.2 Candidiasis Therapeutics Product Category, Application and Specification 6.10.2.1 Product A 6.10.2.2 Product B 6.10.3 Digna Biotech S.L. Candidiasis Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018) 6.10.4 Main Business/Business Overview 6.11 Medivir AB 6.12 Amura Holdings 7 Candidiasis Therapeutics Manufacturing Cost Analysis 7.1 Candidiasis Therapeutics Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Price Trend of Key Raw Materials 7.1.3 Key Suppliers of Raw Materials 7.1.4 Market Concentration Rate of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.2.1 Raw Materials 7.2.2 Labor Cost 7.2.3 Manufacturing Expenses 7.3 Manufacturing Process Analysis of Candidiasis Therapeutics 8 Industrial Chain, Sourcing Strategy and Downstream Buyers 8.1 Candidiasis Therapeutics Industrial Chain Analysis 8.2 Upstream Raw Materials Sourcing 8.3 Raw Materials Sources of Candidiasis Therapeutics Major Manufacturers in 2017 8.4 Downstream Buyers 9 Marketing Strategy Analysis, Distributors/Traders 9.1 Marketing Channel 9.1.1 Direct Marketing 9.1.2 Indirect Marketing 9.1.3 Marketing Channel Development Trend 9.2 Market Positioning 9.2.1 Pricing Strategy 9.2.2 Brand Strategy 9.2.3 Target Client 9.3 Distributors/Traders List 10 Market Effect Factors Analysis 10.1 Technology Progress/Risk 10.1.1 Substitutes Threat 10.1.2 Technology Progress in Related Industry 10.2 Consumer Needs/Customer Preference Change 10.3 Economic/Political Environmental Change 11 China Candidiasis Therapeutics Market Size (Sales and Revenue) Forecast (2018-2025) 11.1 China Candidiasis Therapeutics Sales (K Pcs), Revenue (Million USD) Forecast (2018-2025) 11.2 China Candidiasis Therapeutics Sales (K Pcs) Forecast by Type (2018-2025) 11.3 China Candidiasis Therapeutics Sales (K Pcs) Forecast by Application (2018-2025) 11.4 China Candidiasis Therapeutics Sales (K Pcs) Forecast by Region (2018-2025) 12 Research Findings and Conclusion 13 Methodology and Data Source 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Disclaimer 13.4 Author List

List of Tables and Figures Figure Global and China Market Size (Million USD) Comparison (2013-2025) Table Candidiasis Therapeutics Sales (K Pcs) and Revenue (Million USD) Market Split by Product Type Table Candidiasis Therapeutics Sales (K Pcs) by Application (2013-2025) Figure Product Picture of Candidiasis Therapeutics Table China Candidiasis Therapeutics Sales (K Pcs) and Growth Rate (%) Comparison by Types (Product Category) (2013-2025) Figure China Candidiasis Therapeutics Sales Volume Market Share by Types in 2017 Figure Doxorubicin Product Picture Figure Cisplatin Product Picture Figure 7Carboplatin Product Picture Figure Etoposide Product Picture Figure Ifosfamide Product Picture Figure Cyclophosphamide Product Picture Figure Methotrexate Product Picture Figure Vincristine Product Picture Figure China Candidiasis Therapeutics Sales (K Pcs) Comparison by Application (2013-2025) Figure China Sales Market Share (%) of Candidiasis Therapeutics by Application in 2017 Figure Multispecialty Hospitals Examples Table Key Downstream Customer in Multispecialty Hospitals Figure Cancer Research Institutes Examples Table Key Downstream Customer in Cancer Research Institutes Figure Others Examples Table Key Downstream Customer in Others Figure South China Candidiasis Therapeutics Revenue (Million USD) and Growth Rate (2013-2025) Figure East China Candidiasis Therapeutics Revenue (Million USD) and Growth Rate (2013-2025) Figure Southwest China Candidiasis Therapeutics Revenue (Million USD) and Growth Rate (2013-2025) Figure Northeast China Candidiasis Therapeutics Revenue (Million USD) and Growth Rate (2013-2025) Figure North China Candidiasis Therapeutics Revenue (Million USD) and Growth Rate (2013-2025) Figure Central China Candidiasis Therapeutics Revenue (Million USD) and Growth Rate (2013-2025) Figure China Candidiasis Therapeutics Sales (K Pcs) and Growth Rate (%)(2013-2025) Figure China Candidiasis Therapeutics Revenue (Million USD) and Growth Rate (%)(2013-2025) Table China Candidiasis Therapeutics Sales of Key Players/Manufacturers (2013-2018) Table China Candidiasis Therapeutics Sales Share (%) by Players/Manufacturers (2013-2018) Figure 2017 China Candidiasis Therapeutics Sales Share (%) by Players/Manufacturers Figure 2017 China Candidiasis Therapeutics Sales Share (%) by Players/Manufacturers Table China Candidiasis Therapeutics Revenue by Players/Manufacturers (2013-2018) Table China Candidiasis Therapeutics Revenue Market Share (%) by Players/Manufacturers (2013-2018) Figure 2017 China Candidiasis Therapeutics Revenue Market Share (%) by Players/Manufacturers Figure 2017 China Candidiasis Therapeutics Revenue Market Share (%) by Players/Manufacturers Table China Market Candidiasis Therapeutics Average Price of Key Players/Manufacturers (2013-2018) Figure China Market Candidiasis Therapeutics Average Price of Key Players/Manufacturers in 2017 Figure China Candidiasis Therapeutics Market Share of Top 3 Players/Manufacturers Figure China Candidiasis Therapeutics Market Share of Top 5 Players/Manufacturers Table China Players/Manufacturers Candidiasis Therapeutics Manufacturing Base Distribution and Sales Area Table China Players/Manufacturers Candidiasis Therapeutics Product Category Table China Candidiasis Therapeutics Sales (K Pcs) by Regions (2013-2018) Table China Candidiasis Therapeutics Sales Share (%) by Regions (2013-2018) Figure China Candidiasis Therapeutics Sales Share (%) by Regions (2013-2018) Figure China Candidiasis Therapeutics Sales Market Share (%) by Regions in 2017 Table China Candidiasis Therapeutics Revenue (Million USD) and Market Share by Regions (2013-2018) Table China Candidiasis Therapeutics Revenue Market Share (%) by Regions (2013-2018) Figure China Candidiasis Therapeutics Revenue Market Share (%) by Regions (2013-2018) Figure China Candidiasis Therapeutics Revenue Market Share (%) by Regions in 2017 Table China Candidiasis Therapeutics Price (USD/Pcs) by Regions (2013-2018) Table China Candidiasis Therapeutics Sales (K Pcs) by Type (2013-2018) Table China Candidiasis Therapeutics Sales Share (%) by Type (2013-2018) Figure China Candidiasis Therapeutics Sales Share (%) by Type (2013-2018) Figure China Candidiasis Therapeutics Sales Market Share (%) by Type in 2017 Table China Candidiasis Therapeutics Revenue (Million USD) and Market Share by Type (2013-2018) Table China Candidiasis Therapeutics Revenue Market Share (%) by Type (2013-2018) Figure Revenue Market Share of Candidiasis Therapeutics by Type (2013-2018) Figure Revenue Market Share of Candidiasis Therapeutics by Type in 2017 Table China Candidiasis Therapeutics Price (USD/Pcs) by Types (2013-2018) Figure China Candidiasis Therapeutics Sales Growth Rate (%) by Type (2013-2018) Table China Candidiasis Therapeutics Sales (K Pcs) by Applications (2013-2018) Table China Candidiasis Therapeutics Sales Market Share (%) by Applications (2013-2018) Figure China Candidiasis Therapeutics Sales Market Share (%) by Application (2013-2018) Figure China Candidiasis Therapeutics Sales Market Share (%) by Application in 2017 Table China Candidiasis Therapeutics Sales Growth Rate (%) by Application (2013-2018) Figure China Candidiasis Therapeutics Sales Growth Rate (%) by Application (2013-2018) Table Novartis AG Candidiasis Therapeutics Basic Information List Table Novartis AG Candidiasis Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018) Figure Novartis AG Candidiasis Therapeutics Sales (K Pcs) and Growth Rate (%)(2013-2018) Figure Novartis AG Candidiasis Therapeutics Sales Market Share (%) in China (2013-2018) Figure Novartis AG Candidiasis Therapeutics Revenue Market Share (%) in China (2013-2018) Table Amgen Candidiasis Therapeutics Basic Information List Table Amgen Candidiasis Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018) Figure Amgen Candidiasis Therapeutics Sales (K Pcs) and Growth Rate (%)(2013-2018) Figure Amgen Candidiasis Therapeutics Sales Market Share (%) in China (2013-2018) Figure Amgen Candidiasis Therapeutics Revenue Market Share (%) in China (2013-2018) Table F. Hoffmann-La Roche Ltd. Candidiasis Therapeutics Basic Information List Table F. Hoffmann-La Roche Ltd. Candidiasis Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018) Figure F. Hoffmann-La Roche Ltd. Candidiasis Therapeutics Sales (K Pcs) and Growth Rate (%)(2013-2018) Figure F. Hoffmann-La Roche Ltd. Candidiasis Therapeutics Sales Market Share (%) in China (2013-2018) Figure F. Hoffmann-La Roche Ltd. Candidiasis Therapeutics Revenue Market Share (%) in China (2013-2018) Table Bayer-Algeta Candidiasis Therapeutics Basic Information List Table Bayer-Algeta Candidiasis Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018) Figure Bayer-Algeta Candidiasis Therapeutics Sales (K Pcs) and Growth Rate (%)(2013-2018) Figure Bayer-Algeta Candidiasis Therapeutics Sales Market Share (%) in China (2013-2018) Figure Bayer-Algeta Candidiasis Therapeutics Revenue Market Share (%) in China (2013-2018) Table Merrion Pharmaceuticals Plc. Candidiasis Therapeutics Basic Information List Table Merrion Pharmaceuticals Plc. Candidiasis Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018) Figure Merrion Pharmaceuticals Plc. Candidiasis Therapeutics Sales (K Pcs) and Growth Rate (%)(2013-2018) Figure Merrion Pharmaceuticals Plc. Candidiasis Therapeutics Sales Market Share (%) in China (2013-2018) Figure Merrion Pharmaceuticals Plc. Candidiasis Therapeutics Revenue Market Share (%) in China (2013-2018) Table Ablynx Candidiasis Therapeutics Basic Information List Table Ablynx Candidiasis Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018) Figure Ablynx Candidiasis Therapeutics Sales (K Pcs) and Growth Rate (%)(2013-2018) Figure Ablynx Candidiasis Therapeutics Sales Market Share (%) in China (2013-2018) Figure Ablynx Candidiasis Therapeutics Revenue Market Share (%) in China (2013-2018) Table Genta Incorporated Candidiasis Therapeutics Basic Information List Table Genta Incorporated Candidiasis Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018) Figure Genta Incorporated Candidiasis Therapeutics Sales (K Pcs) and Growth Rate (%)(2013-2018) Figure Genta Incorporated Candidiasis Therapeutics Sales Market Share (%) in China (2013-2018) Figure Genta Incorporated Candidiasis Therapeutics Revenue Market Share (%) in China (2013-2018) Table Galapagos NV Candidiasis Therapeutics Basic Information List Table Galapagos NV Candidiasis Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018) Figure Galapagos NV Candidiasis Therapeutics Sales (K Pcs) and Growth Rate (%)(2013-2018) Figure Galapagos NV Candidiasis Therapeutics Sales Market Share (%) in China (2013-2018) Figure Galapagos NV Candidiasis Therapeutics Revenue Market Share (%) in China (2013-2018) Table Catena Pharmaceuticals Inc. Candidiasis Therapeutics Basic Information List Table Catena Pharmaceuticals Inc. Candidiasis Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018) Figure Catena Pharmaceuticals Inc. Candidiasis Therapeutics Sales (K Pcs) and Growth Rate (%)(2013-2018) Figure Catena Pharmaceuticals Inc. Candidiasis Therapeutics Sales Market Share (%) in China (2013-2018) Figure Catena Pharmaceuticals Inc. Candidiasis Therapeutics Revenue Market Share (%) in China (2013-2018) Table Digna Biotech S.L. Candidiasis Therapeutics Basic Information List Table Digna Biotech S.L. Candidiasis Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018) Figure Digna Biotech S.L. Candidiasis Therapeutics Sales (K Pcs) and Growth Rate (%)(2013-2018) Figure Digna Biotech S.L. Candidiasis Therapeutics Sales Market Share (%) in China (2013-2018) Figure Digna Biotech S.L. Candidiasis Therapeutics Revenue Market Share (%) in China (2013-2018) Table Medivir AB Candidiasis Therapeutics Basic Information List Table Amura Holdings Candidiasis Therapeutics Basic Information List Table Production Base and Market Concentration Rate of Raw Material Figure Price Trend of Key Raw Materials Table Key Suppliers of Raw Materials Figure Manufacturing Cost Structure of Candidiasis Therapeutics Figure Manufacturing Process Analysis of Candidiasis Therapeutics Figure Candidiasis Therapeutics Industrial Chain Analysis Table Raw Materials Sources of Candidiasis Therapeutics Major Players/Manufacturers in 2017 Table Major Buyers of Candidiasis Therapeutics Table Distributors/Traders List Figure China Candidiasis Therapeutics Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025) Figure China Candidiasis Therapeutics Revenue (Million USD) and Growth Rate Forecast (2018-2025) Figure China Candidiasis Therapeutics Price (USD/Pcs) Trend Forecast (2018-2025) Table China Candidiasis Therapeutics Sales (K Pcs) Forecast by Type (2018-2025) Figure China Candidiasis Therapeutics Sales (K Pcs) Forecast by Type (2018-2025) Figure China Candidiasis Therapeutics Sales Volume Market Share Forecast by Type in 2025 Table China Candidiasis Therapeutics Sales (K Pcs) Forecast by Application (2018-2025) Figure China Candidiasis Therapeutics Sales Volume Market Share Forecast by Application (2018-2025) Figure China Candidiasis Therapeutics Sales Volume Market Share Forecast by Application in 2025 Table China Candidiasis Therapeutics Sales (K Pcs) Forecast by Regions (2018-2025) Table China Candidiasis Therapeutics Sales Volume Share Forecast by Regions (2018-2025) Figure China Candidiasis Therapeutics Sales Volume Share Forecast by Regions (2018-2025) Figure China Candidiasis Therapeutics Sales Volume Share Forecast by Regions in 2025 Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources